Suppr超能文献

印度古吉拉特邦新冠病毒(SARS-CoV-2)倾向性D614G突变的进化与抗原分析

Evolutionary and Antigenic Profiling of the Tendentious D614G Mutation of SARS-CoV-2 in Gujarat, India.

作者信息

Nimavat Jay, Mootapally Chandrashekar, Nathani Neelam M, Dave Devyani, Kher Mukesh N, Mahajan Mayur S, Joshi Chaitanya G, Bhatt Vaibhav D

机构信息

Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, India.

School of Applied Sciences and Technology (GTU-SAST), Gujarat Technological University, Ahmedabad, India.

出版信息

Front Genet. 2021 Nov 11;12:764927. doi: 10.3389/fgene.2021.764927. eCollection 2021.

Abstract

Humankind has suffered many pandemics in history including measles, SARS, MERS, Ebola, and recently the novel Coronavirus disease caused by SARS-CoV-2. As of September 2021, it has affected over 200 million people and caused over 4 million deaths. India is the second most affected country in the world. Up to this date, more than 38 Lakh viral genomes have been submitted to public repositories like GISAID and NCBI to analyze the virus phylogeny and mutations. Here, we analyzed 2349 genome sequences of SARS-CoV-2 submitted in GISAID by a single institute pertaining to infections from the Gujarat state to know their variants and phylogenetic distributions with a major focus on the spike protein. More than 93% of the genomes had one or more mutations in the spike glycoprotein. The D614G variant in spike protein is reported to have a very high frequency of >95% globally followed by the L452R and P681R, thus getting significant attention. The antigenic propensity of a small peptide of 29 residues from 597 to 625 of the spike protein variants having D614 and G614 showed that G614 has a little higher antigenic propensity. Thus, the D614G is the cause for higher viral antigenicity, however, it has not been reported to be effective to be causing more deaths.

摘要

人类历史上遭受过许多大流行病,包括麻疹、非典、中东呼吸综合征、埃博拉,以及最近由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的新型冠状病毒病。截至2021年9月,它已影响超过2亿人,并导致超过400万人死亡。印度是世界上受影响第二严重的国家。截至目前,已有超过380万个病毒基因组被提交到全球共享流感数据倡议组织(GISAID)和美国国立生物技术信息中心(NCBI)等公共数据库,以分析病毒的系统发育和突变情况。在此,我们分析了由一个机构提交至GISAID的2349个SARS-CoV-2基因组序列,这些序列与古吉拉特邦的感染情况有关,以了解其变体和系统发育分布,主要关注刺突蛋白。超过93%的基因组在刺突糖蛋白中存在一个或多个突变。据报道,刺突蛋白中的D614G变体在全球的频率非常高,超过95%,其次是L452R和P681R,因此受到了极大关注。对具有D614和G614的刺突蛋白变体中597至625位29个残基的小肽的抗原倾向分析表明,G614的抗原倾向略高。因此,D614G是病毒抗原性较高的原因,然而,尚未报道它会导致更多死亡。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验